Clinical Origin and Species Distribution of Fusarium spp. Isolates Identified by Molecular Sequencing and Mass Spectrometry: A European Multicenter Hospital Prospective Study - Centre de recherche Saint-Antoine - UMR S938 Accéder directement au contenu
Article Dans Une Revue Journal of Fungi Année : 2021

Clinical Origin and Species Distribution of Fusarium spp. Isolates Identified by Molecular Sequencing and Mass Spectrometry: A European Multicenter Hospital Prospective Study

Sophie Brun
  • Fonction : Auteur
  • PersonId : 1094796
Sophie Cassaing
  • Fonction : Auteur
  • PersonId : 1094798
Christine Schuttler
  • Fonction : Auteur
Lilia Hasseine
  • Fonction : Auteur
  • PersonId : 1094799
Damien Costa
Christine Bonnal
  • Fonction : Auteur
  • PersonId : 977140
Laurence Delhaes
  • Fonction : Auteur
  • PersonId : 1094801
Arnaud Riat
  • Fonction : Auteur
  • PersonId : 1094802
Lise Kristensen
  • Fonction : Auteur
  • PersonId : 1094803
Marcel Brandenberger
  • Fonction : Auteur
  • PersonId : 1094804
Ann Packeu
  • Fonction : Auteur
  • PersonId : 1094806

Résumé

Fusarium spp. are widespread environmental fungi as well as pathogens that can affect plants, animals and humans. Yet the epidemiology of human fusariosis is still cloudy due to the rapidly evolving taxonomy. The Mass Spectrometry Identification database (MSI) has been developed since 2017 in order to allow a fast, accurate and free-access identification of fungi by matrix-assisted laser desorption ionization—time of flight (MALDI-TOF) mass spectrometry. Taking advantage of the MSI database user network, we aim to study the species distribution of Fusarium spp. isolates in an international multicenter prospective study. This study also allowed the assessment of the abilities of miscellaneous techniques to identify Fusarium isolates at the species level. The identification was performed by PCR-sequencing and phylogenic-tree approach. Both methods are used as gold standard for the evaluation of mass spectrometry. Identification at the species complex was satisfactory for all the tested methods. However, identification at the species level was more challenging and only 32% of the isolates were correctly identified with the National Center for Biotechnology Information (NCBI) DNA database, 20% with the Bruker MS database and 43% with the two MSI databases. Improvement of the mass spectrometry database is still needed to enable precise identification at the species level of any Fusarium isolates encountered either in human pathology or in the environment.
Fichier principal
Vignette du fichier
jof-07-00246-v2.pdf (1.49 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03184998 , version 1 (30-03-2021)

Identifiants

Citer

Anne-Cécile Normand, Sébastien Imbert, Sophie Brun, Abdullah M S Al-Hatmi, Erja Chryssanthou, et al.. Clinical Origin and Species Distribution of Fusarium spp. Isolates Identified by Molecular Sequencing and Mass Spectrometry: A European Multicenter Hospital Prospective Study. Journal of Fungi, 2021, 7 (4), pp.246. ⟨10.3390/jof7040246⟩. ⟨hal-03184998⟩
126 Consultations
70 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More